News and Announcements
Universal Biosensors Appoints Craig Coleman as Non-Executive Director
- Published July 04, 2016 2:58PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
30th June 2016, ASX Announcement
Universal Biosensors, Inc (ASX: UBI) today announced the appointment of Mr. Craig Coleman as a non-executive director to the Board of Universal Biosensors. This appointment continues the board renewal process which has occurred over recent years, with the appointment of Ms. Judith Smith in 2015 and Mr. David Hoey in 2016.
Mr. Colemans career of 30 years has spanned banking and finance, corporate advisory and funds management. During his executive career, he has been a Managing Director of a publicly listed company (Home Building Society Ltd) and prior to this, held a number of senior executive positions with ANZ Banking Group Ltd, including Managing Director Banking Products, Managing Director Wealth Management, Non-Executive Director E*TRADE Australia Ltd and Head of Retail Banking New Zealand.
To view the full announcement, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
